However, trialresultsrecentlyshowedthatitonlyoffersminimalprotectionagainstmildtomoderateinfectionby a variantthathasbeendominatinginSouthAfricaandhasspreadtonineothercountriestoday.
Whgavethe W.
H.
O hassaidtheAstraZenecavaccineissafeandeffectiveandshouldstillbeusedincountriesevenwherethevariantiscirculating.